COVAX cuts global COVID vaccine supply estimates by a quarter

New hope for antibody to treat muscular dystrophy
13 September 2021
Immune checkpoint inhibitors convey survival benefit in elderly patients with stage IV non-small cell lung cancer
13 September 2021

COVAX cuts global COVID vaccine supply estimates by a quarter

(HealthDay)—Fewer COVID-19 vaccine doses than expected will be available through the global COVAX program, affecting many less-affluent nations waiting on these doses.

Comments are closed.